For HCPs Only
Recent Clinical Updates
Loading latest clinical updates
SUSPENSION

FDA Drug Reference

Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone

Dosage Form

SUSPENSION

Route

ORAL

NDC

60687-888

This page summarizes official FDA drug label records for professional reference. Verify prescribing decisions against the complete current label and institutional policy.

Label Record Status

Data from U.S. Food and Drug Administration label records. Listing expiration: Date unavailable

Clinical Pharmacology

Indications & Usage

Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone is listed as a SUSPENSION formulation in the SUSPENSION category. Consult official FDA labeling for full prescribing information.

Administration Context

Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone is administered via the ORAL route as a SUSPENSION.

Administration Protocol

Prescribing Information

Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.

Safety Profile

Contraindications & Warnings

Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.

National Drug Registry

Product and label metadata.

Marketing Category

OTC MONOGRAPH DRUG

Route of Administration

ORAL

National Drug Code

60687-888

Manufacturer / Labeler

American Health Packaging

Dosage Form

SUSPENSION

Strength

See labeling

Application Number

M002

SPL Identifier

39fbaa0c-00d4-898a-e063-6394a90a5a7e

WHO Regulatory Intelligence

Vaccine Safety Information

Access evidence-based safety data and clinical guidelines from global health resources.

View Vaccine Safety